USD
+$0.00
(+0.00%
)At Close (As of Sep 2, 2025)
$105.06M
Market Cap
-
P/E Ratio
-2.39
EPS
$15.04
52 Week High
$1.60
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$502K |
Total Revenue | $0 |
Cost Of Revenue | $502K |
Costof Goods And Services Sold | $502K |
Operating Income | -$69M |
Selling General And Administrative | $22M |
Research And Development | $47M |
Operating Expenses | $68M |
Investment Income Net | - |
Net Interest Income | $7.5M |
Interest Income | $8.9M |
Interest Expense | $1.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$5.8M |
Income Before Tax | -$61M |
Income Tax Expense | -$61M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$61M |
Comprehensive Income Net Of Tax | - |
Ebit | -$63M |
Ebitda | -$69M |
Net Income | -$61M |
Field | Value (USD) |
---|---|
Total Assets | $178M |
Total Current Assets | $169M |
Cash And Cash Equivalents At Carrying Value | $168M |
Cash And Short Term Investments | $168M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $8.2M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $1.1M |
Other Non Current Assets | - |
Total Liabilities | $26M |
Total Current Liabilities | $10M |
Current Accounts Payable | $1.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $870K |
Total Non Current Liabilities | $16M |
Capital Lease Obligations | $5.4M |
Long Term Debt | $12M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $17M |
Other Current Liabilities | $7.6M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $151M |
Treasury Stock | - |
Retained Earnings | -$138M |
Common Stock | $3K |
Common Stock Shares Outstanding | $25M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$47M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $502K |
Capital Expenditures | $2.1M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$2.1M |
Cashflow From Financing | $136M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$61M |
Field | Value (USD) |
---|---|
Gross Profit | -$502K |
Total Revenue | $0 |
Cost Of Revenue | $502K |
Costof Goods And Services Sold | $502K |
Operating Income | -$69M |
Selling General And Administrative | $22M |
Research And Development | $47M |
Operating Expenses | $68M |
Investment Income Net | - |
Net Interest Income | $7.5M |
Interest Income | $8.9M |
Interest Expense | $1.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$5.8M |
Income Before Tax | -$61M |
Income Tax Expense | -$61M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$61M |
Comprehensive Income Net Of Tax | - |
Ebit | -$63M |
Ebitda | -$69M |
Net Income | -$61M |
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.